PURPOSE: To test the hypothesis that the robust expansion of bovine corneal endothelial cells (BCECs) in vitro is due to the presence of individual endothelial cells with various levels of proliferative potential. METHODS: BCECs and bovine vascular endothelial cells (ECs) derived from aorta, coronary artery, and pulmonary artery were cultivated in optimized medium. These cell populations were confirmed by morphologic features, functional assays, and gene expression profiles. Moreover, ECs were plated in a single-cell clonogenic assay to evaluate colony-forming ability. RESULTS: Both corneal and vascular ECs were confirmed to be pure populations of endothelium uncontaminated with hematopoietic cells. A complete hierarchy of endothelial colony-forming cells (ECFCs) was identified in BCECs by a single-cell clonogenic assay. The distribution of the various types of ECFCs was similar to the control ECs removed from the systemic vessels. CONCLUSIONS: Cultured BCECs display clonal proliferative properties similar to those of vascular ECs.
PURPOSE: To test the hypothesis that the robust expansion of bovine corneal endothelial cells (BCECs) in vitro is due to the presence of individual endothelial cells with various levels of proliferative potential. METHODS: BCECs and bovine vascular endothelial cells (ECs) derived from aorta, coronary artery, and pulmonary artery were cultivated in optimized medium. These cell populations were confirmed by morphologic features, functional assays, and gene expression profiles. Moreover, ECs were plated in a single-cell clonogenic assay to evaluate colony-forming ability. RESULTS: Both corneal and vascular ECs were confirmed to be pure populations of endothelium uncontaminated with hematopoietic cells. A complete hierarchy of endothelial colony-forming cells (ECFCs) was identified in BCECs by a single-cell clonogenic assay. The distribution of the various types of ECFCs was similar to the control ECs removed from the systemic vessels. CONCLUSIONS: Cultured BCECs display clonal proliferative properties similar to those of vascular ECs.
Authors: Mervin C Yoder; Laura E Mead; Daniel Prater; Theresa R Krier; Karim N Mroueh; Fang Li; Rachel Krasich; Constance J Temm; Josef T Prchal; David A Ingram Journal: Blood Date: 2006-10-19 Impact factor: 22.113
Authors: Carmen Ramírez-Castillejo; Francisco Sánchez-Sánchez; Celia Andreu-Agulló; Sacri R Ferrón; J Daniel Aroca-Aguilar; Pilar Sánchez; Helena Mira; Julio Escribano; Isabel Fariñas Journal: Nat Neurosci Date: 2006-02-19 Impact factor: 24.884
Authors: David P Basile; Pingyu Zeng; Jessica L Friedrich; Ellen C Leonard; Mervin C Yoder Journal: Microcirculation Date: 2012-10 Impact factor: 2.628
Authors: W Chris Shelley; Alyssa C Leapley; Lan Huang; Paul J Critser; Pingyu Zeng; Daniel Prater; David A Ingram; Alice F Tarantal; Mervin C Yoder Journal: Pediatr Res Date: 2011-12-21 Impact factor: 3.756
Authors: Wing Yan Yu; Carl Sheridan; Ian Grierson; Sharon Mason; Victoria Kearns; Amy Cheuk Yin Lo; David Wong Journal: J Biomed Biotechnol Date: 2011-12-06
Authors: Kathryn L McCabe; Noelia J Kunzevitzky; Brian P Chiswell; Xin Xia; Jeffrey L Goldberg; Robert Lanza Journal: PLoS One Date: 2015-12-21 Impact factor: 3.240
Authors: Thore Schmedt; Yuming Chen; Tracy T Nguyen; Shimin Li; Joseph A Bonanno; Ula V Jurkunas Journal: PLoS One Date: 2012-12-21 Impact factor: 3.240